We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Cysteamine 5% cream (topical depigmenting agent)
A newer non-hydroquinone skin-lightening cream for melasma — an aminothiol naturally present in cells, applied to the skin. The honest framing: cysteamine 5% has a genuinely respectable evidence base — multiple double-blind placebo-controlled RCTs and a 2024 meta-analysis show it significantly beats placebo for melasma, and several head-to-head trials pit it against hydroquinone and triple-combination creams. But its ceiling is capped: against hydroquinone it is non-superior (and in one direct comparison actually inferior), trials are small and several share a manufacturer-affiliated author, and its main real-world drawback is tolerability — a characteristic sulfur odor plus erythema/burning. A credible, hydroquinone-free alternative, not a clear upgrade.
Topical cosmetic ingredient — not a dietary supplement
Cysteamine (topical) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Cysteamine (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2015–2025 with a typical study size of 65 participants.
Based on 13 studies · 2 meta-analyses · 8 RCTs · 105 total participants
Confidence
High confidenceBy outcome
Multiple double-blind placebo-controlled RCTs and a 2024 meta-analysis show cysteamine 5% significantly beats placebo for melasma, with unusual breadth of head-to-head data — but against hydroquinone it is non-superior (and inferior in one direct comparison), trials are small and partly manufacturer-affiliated, and tolerability/odor limit real-world use.
13 rigorous studies
9 randomized trials · 2 meta-analyses · 2 systematic reviews
Our evidence rating for Cysteamine (topical) is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
No trials currently enrolling · 4 completed on ClinicalTrials.gov
1 of the completed trials have posted results
Registered trials show research momentum for Cysteamine (topical), not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Aug 2026
Cysteamine (2-aminoethanethiol) is an aminothiol naturally present in cells (a breakdown product of coenzyme A) used topically at 5% as a non-hydroquinone depigmenting cream for melasma and hyperpigmentation. This entry covers TOPICAL cosmetic use.
Mechanistically it inhibits tyrosinase and key downstream steps of melanin synthesis, acts as an intracellular antioxidant/thiol that diverts pigment-forming intermediates, and chelates the copper/iron involved in melanogenesis.
The clinical evidence is, for a newer agent, unusually solid: two double-blind placebo-controlled RCTs (Mansouri et al., 2015, n=50; Farshi et al., 2018, n=40) both showed significantly lower MASI with cysteamine 5% than placebo over four months, and a 2024 systematic review and meta-analysis of seven RCTs confirmed a significant pooled effect versus placebo (SMD -0.84, I²=0%).
It also has unusual breadth of head-to-head data: against modified Kligman's formula it performed at least as well with better tolerability (Karrabi et al., 2021), and against hydroquinone 4%/ascorbic acid it was equivalent on MASI (Sepaskhah et al., 2022).
The honest counter-evidence caps the score: the meta-analysis found no significant difference versus hydroquinone 4% (non-superiority, not superiority), and the best evaluator-blinded direct comparison (Lima et al., 2020) found cysteamine actually inferior to hydroquinone on mMASI and quality of life.
Trials are small (n=40-65), several share Iranian centers and a manufacturer-affiliated co-author, durations are short (~4 months), and the practical limitations are real: cysteamine has a characteristic unpleasant sulfur/thiol odor and commonly causes erythema and burning.
So the honest summary: topical cysteamine 5% is an evidence-backed, hydroquinone-free option for melasma with a safer long-term profile (no ochronosis), but it is roughly hydroquinone-equivalent at best, with tolerability/odor as the main barrier to adherence. None of this is a health claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Cysteamine inhibits tyrosinase and downstream steps of melanin synthesis, and as an intracellular aminothiol it acts as an antioxidant that diverts pigment-forming intermediates (e.g. dopaquinone) away from melanin. It also chelates the copper/iron involved in melanogenesis.
Unlike hydroquinone, cysteamine is a naturally occurring molecule that is not melanocyte-cytotoxic and is not associated with exogenous ochronosis, which is the basis for positioning it as a safer long-term, hydroquinone-free option.
Limited data for topical cysteamine in pregnancy; discuss with a clinician (azelaic acid is the better-studied option).
Use short-contact application and build tolerance; erythema/burning are common early.
A reasonable hydroquinone-free alternative with no ochronosis risk, accepting roughly comparable efficacy and the odor/irritation trade-off.
Combining with other irritants can worsen erythema/burning; introduce gradually and use short-contact application. Not a systemic interaction — it is not ingested.
Tip: Use short-contact application (rinse after ~15 min), moisturize, and reduce frequency if needed.
Tip: Short-contact use and rinsing reduce the smell; it is the main adherence barrier.
Cysteamine (topical) has an evidence score of 6/10 — moderate evidence based on 13 indexed studies, including 1 meta-analysis. A newer non-hydroquinone skin-lightening cream for melasma — an aminothiol naturally present in cells, applied to the skin. The honest framing: cysteamine 5% has a genuinely respectable evidence base — multiple double-blind placebo-controlled RCTs and a 2024 meta-analysis show it significantly beats placebo for melasma, and several head-to-head trials pit it against hydroquinone and triple-combination creams. But its ceiling is capped: against hydroquinone it is non-superior (and in one direct comparison actually inferior), trials are small and several share a manufacturer-affiliated author, and its main real-world drawback is tolerability — a characteristic sulfur odor plus erythema/burning. A credible, hydroquinone-free alternative, not a clear upgrade. Representative study: PMID 39673630.
The commonly studied dose of Cysteamine (topical) is Topical cosmetic. Cysteamine 5% cream is typically applied once daily to areas of melasma as a short-contact treatment (left on for ~15 minutes, then washed off) to limit odor and irritation, with daily sunscreen. There is no oral or systemic use in this context. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Cysteamine (topical) — consistent daily use matters more than the time of day. Cysteamine cream is a leave-on/short-contact topical with no meal-timing relationship; many protocols use a ~15-minute contact time then rinse to reduce odor and irritation.
Cysteamine (topical) is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are erythema and burning, unpleasant sulfur/thiol odor. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy/sensitivity to cysteamine; Application to broken, irritated, or sunburned skin until healed.
Sunscreen (SPF)
Mostly mechanism / observationalDaily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.
Tretinoin (Retin-A)
Mostly mechanism / observationalA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
Azelaic Acid
Mostly mechanism / observationalA topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route.
Hydroquinone
Mostly mechanism / observationalThe long-standing gold-standard topical skin-lightening agent for melasma and hyperpigmentation — and now a regulated drug, not a cosmetic. Hydroquinone (HQ) competitively inhibits tyrosinase and is toxic to overactive pigment cells. The honest framing: it is the most rigorously studied and most effective topical depigmenter — a large pivotal RCT, a Cochrane review, and recent meta-analyses all use HQ 4% (and the 'Kligman' triple-combination with a retinoid + steroid) as the benchmark that newer agents are measured against and rarely beat. But it carries real liabilities: irritation, rebound pigmentation, and — with prolonged or high-strength use — a disfiguring complication called exogenous ochronosis. For these reasons it was pulled from US over-the-counter sale in 2020 (now prescription-only) and is restricted in the EU and elsewhere. Effective, but for monitored, time-limited medical use.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 13 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.